Analytical Data
-
基因名
RNASEP
- Application
-
别名
RNASEP；Ribonuclease P Protein subunit p38
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P78346
-
表达区间
2-268aa
-
氨基酸序列
AVFADLDLR AGSDLKALRG LVETAAHLGY SVVAINHIVD FKEKKQEIEK PVAVSELFTT LPIVQGKSRP IKILTRLTII VSDPSHCNVL RATSSRARLY DVVAVFPKTE KLFHIACTHL DVDLVCITVT EKLPFYFKRP PINVAIDRGL AFELVYSPAI KDSTMRRYTI SSALNLMQIC KGKNVIISSA AERPLEIRGP YDVANLGLLF GLSESDAKAA VSTNCRAALL HGETRKTAFG IISTVKKPRP SEGDEDCLPA SKKAKCEG
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RNASEP (Ribonuclease A Superfamily Protein) is a member of the ribonuclease A superfamily, known for its ribonucleolytic activity and involvement in various biological processes, including RNA metabolism, apoptosis, and immune responses. The interest in RNASEP has surged due to its potential applications in therapeutics and biotechnology. Research has shown that recombinant forms of RNASEP can be engineered to enhance their enzymatic properties or target specific RNA molecules, making them valuable tools in molecular biology and medicine. Moreover, RNASEP's ability to selectively degrade RNA has garnered attention for its implications in RNA-based therapies, including viral infections and cancer treatments, where modulating RNA levels can impact disease progression. Understanding the structure-function relationship of RNASEP through recombinant engineering can pave the way for the development of novel therapeutic strategies and innovative biotechnological applications, emphasizing its significance in both fundamental research and clinical applications. Continued investigation into RNASEP and its variants may lead to breakthroughs in understanding RNA biology and the development of RNA-targeted therapeutics.
